IRIS
CACCIOLA, Irene
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.399
NA - Nord America 1.357
AS - Asia 254
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
OC - Oceania 1
Totale 3.015
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.355
IE - Irlanda 487
SE - Svezia 412
IT - Italia 235
CN - Cina 216
UA - Ucraina 63
DE - Germania 55
FI - Finlandia 37
PL - Polonia 37
GB - Regno Unito 30
IN - India 27
BE - Belgio 22
FR - Francia 8
RU - Federazione Russa 8
VN - Vietnam 5
IR - Iran 3
CA - Canada 2
CL - Cile 2
EU - Europa 2
AU - Australia 1
BD - Bangladesh 1
CH - Svizzera 1
ES - Italia 1
HR - Croazia 1
KZ - Kazakistan 1
MD - Moldavia 1
MY - Malesia 1
NO - Norvegia 1
Totale 3.015
Salva come PNG Salva come JPEG
Città #
Dublin 487
Chandler 294
Nyköping 279
Jacksonville 146
Messina 108
Beijing 84
Ashburn 77
Ann Arbor 75
Princeton 67
Medford 62
Des Moines 50
Dearborn 44
Cambridge 40
Warsaw 30
Boardman 24
Jinan 23
Brussels 22
Rosolini 19
Woodbridge 19
New York 16
Hyderabad 15
Nanjing 15
Rome 12
San Mateo 12
Wilmington 12
Hebei 11
Seattle 11
Pune 10
Shenyang 10
Avola 9
Catania 9
Houston 9
Haikou 8
Tianjin 8
Bremen 7
Pachino 7
Los Angeles 6
Fuzhou 5
Guangzhou 5
Hangzhou 5
Palermo 5
Taizhou 5
Zhengzhou 5
Dong Ket 4
Falls Church 4
Nanchang 4
Radomsko 4
Auburn Hills 3
Caltagirone 3
Changsha 3
Lanzhou 3
Ningbo 3
Qingdao 3
Redwood City 3
Tappahannock 3
Washington 3
Ardabil 2
Bologna 2
Chengdu 2
Clearwater 2
Cradley 2
Culver City 2
Fiumefreddo di Sicilia 2
Frontone 2
Helsinki 2
Jiaxing 2
Lamézia 2
Leawood 2
Mannheim 2
Marlow 2
Milan 2
Norwalk 2
Nuremberg 2
Scandicci 2
Sortino 2
Taiyuan 2
Viagrande 2
Villejuif 2
Yicheng 2
Alcamo 1
Almaty 1
Augusta 1
Bracknell 1
Carrara 1
Chicago 1
Chisinau 1
Edinburgh 1
Giarre 1
Hanoi 1
Hefei 1
Jeffries 1
Kiev 1
Kish 1
Klang 1
Kunming 1
Lancaster 1
Manchester 1
Modesto 1
Monmouth Junction 1
Montréal 1
Totale 2.277
Salva come PNG Salva come JPEG
Nome #
Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography 103
Lack of the NS5B S282T mutation in HCV isolates from liver tissue of naive patients with HCV genotype-1b infection. 102
Atrial fibrillation in patients with cirrhosis 94
Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases 81
NS3 Variability in Hepatitis C Virus Genotype 1A Isolates from Liver Tissue and Serum Samples of Treatment-Naïve Patients with Chronic Hepatitis C 78
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients 77
Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C 66
Fibroscan: a new non-invasive method for evaluation of liver dysfunction in Turner syndrome 66
Elective endoscopic variceal ligation is not a risk factor for bacterial infection in patients with liver cirrhosis 64
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study 63
TT virus has a ubiquitous diffusion in human body tissues: analyses of paired serum and tissue samples. 59
Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis. 59
Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients. 59
Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection 58
Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses. 58
INTRAHEPATIC HDV RNA, HBV DNA, AND HBV RNAS QUANTIFICATIONS REVEAL SUPPRESSION OF HBV PREGENOME RNA PRODUCTION WITH MAINTENANCE OF PRES/S TRNSCRITION IN HDV/HBV CO-INFECTED PATIENTS 56
Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy 56
Oscillazione dei livelli di viremia in soggetti portatori cromici asintomatici di infezione da virus B. Dati preliminari 56
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial. 56
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents. 54
Infezione occulta da virus dell’epatite B in pazienti con epatite cronica virus con correlata valutazione istologica 52
NS3 Q80K Polymorphism in viral isolates from Liver Tissues and serum samples of naive HCV genotype 1a Patients 52
Behaviour of occult HBV infection in HCV-infected patients under treatment with direct-acting antivirals 52
Oscillazione dei livelli di viremia in soggetti portatori cronici asintomatici di infezione da virus b. Dati preliminari 51
Evaluation of liver enzyme levels and identification of asymptomatic liver disease patients in primary care 51
The HCV Sicily Network: A web-based model for the management of HCV chronic liver diseases 51
Prevalence of hepatitis B and C viral infections in hospitalized patients with increased liver enzyme levels and with no known history of hepatic disease 51
Long-term response to interferon alpha is unrelated to "interferon sensitivity determining region" variability in patients with chronic hepatitis C virus-1b infection 50
Molecular analyses of TT virus in paired and tissue samples from 150 patients with either hepatic or non-hepatic disease 48
Pre-S2 defective hepatitis B virus infection in patients with fulminant hepatitis. 48
Impact of Occult Hepatitis B Virus Infection on the Outcome of Chronic Hepatitis C. 48
Virological profiles in patients with chronic hepatitis C and overt or occult HBV infection. 46
PREVALENCE OF BACTERIAL RESISTANCE IN CIRRHOTIC PATIENTS WITH BACTERIAL INFECTION: A PRELIMINARY REPORT 46
Effectiveness of add-on Pegylated interferon alfa-2a therapy in a Lamivudine-treated patient with chronic hepatitis B 46
Hepatitis B virus PreS/S gene variants: Pathobiology and clinical implications. 46
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 46
Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease 45
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis. 44
Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? The REAL Experience 44
Strain endocardico longitudinale tra pazienti cirrotici di classe A e B al punteggio di Child-Pugh 43
Virological profiles in hepatitis B virus inactive carriers: monthly evaluation in 1-year follow-up study 42
Genomic heterogeneity of hepatitis B virus (HBV) and outcome of perinatal HBV infection. 42
Fever and rhomboid target lesion in decompensated cirrhosis 42
Mucocutaneous toxicity during simeprevir treatment for hepatitis C. A single institution, retrospective case series 42
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 42
Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis 42
New-Onset Atrial Fibrillation and Early Mortality Rate in COVID-19 Patients: Association with IL-6 Serum Levels and Respiratory Distress 40
Erectile dysfunction in compensated liver cirrhosis 39
Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate 38
Occult hepatitis B virus infection 37
Antibody to hepatitis B virus core antigen positivity is a predictor of non-alcoholic fatty liver disease severity 37
Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection. 36
Dermatiti iatrogene in corso di trattamento dell’epatopatia HCV-correlata con simeprevir 35
Outcome of cutaneous psoriasis in hepatitis C virus-infected patients treated with Direct-Acting Antiviral therapy 34
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 31
Rate of hepatocellular carcinoma diagnosis in cirrhotic patients with ultrasound‑detected liver nodules 30
The impact of infection by multidrug-resistant agents in patients with cirrhosis. A multicenter prospective study 27
Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance 24
null 22
Effects of Proton Pump Inhibitors in Cirrhotic Patients: What Do We Really Know? 21
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 20
null 19
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis 19
Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST-HCV cohort 15
Incidence and Recurrence of Portal Vein Thrombosis in Cirrhotic Patients 14
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 14
A Keynesian perspective on the health economics of kidney transplantation would strengthen the value of the whole organ donation and transplantation service 10
High Prevalence of Severe Hepatic Fibrosis in Type 2 Diabetic Outpatients Screened for Non-Alcoholic Fatty Liver Disease 8
Assessing Genomic Mutations in SARS-CoV-2: Potential Resistance to Antiviral Drugs in Viral Populations from Untreated COVID-19 Patients 6
Impact of Sex and Gender on Clinical Management of Patients with Advanced Chronic Liver Disease and Type 2 Diabetes 6
A Keynesian perspective on the health economics of kidney transplantation would strengthen the value of the whole organ donation and transplantation service 6
RESIST-HCV criteria to monitor progression of low-risk esophageal varices in patients with compensated cirrhosis after HCV eradication. The SIMPLE study 5
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination 4
Impact of Sex and Gender on Clinical Management of Patients with Advanced Chronic Liver Disease and Type 2 Diabetes 3
High Prevalence of Severe Hepatic Fibrosis in Type 2 Diabetic Outpatients Screened for Non-Alcoholic Fatty Liver Disease 3
Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance 3
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination 2
Health economics aspects of kidney transplantation in Sicily: a benchmark analysis on activity and estimated savings 2
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents 1
Totale 3.188
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.402
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.402
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20198 0 0 0 0 0 0 0 0 0 0 3 5
2019/2020331 31 13 4 12 6 48 42 27 9 81 51 7
2020/2021408 35 4 84 16 48 30 21 48 39 45 22 16
2021/2022481 13 53 14 14 36 4 52 11 7 66 65 146
2022/20231.352 81 162 73 89 86 127 32 77 558 7 39 21
2023/2024304 27 66 23 40 32 47 8 11 3 45 2 0
Totale 3.188